2025 Q4 -tulosraportti
3 päivää sitten
‧1 t 4 min
Tarjoustasot
Määrä
Osto
270
Myynti
Määrä
19
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
16,36VWAP
Alin
15,6VaihtoMäärä
89,7 9 414 615
VWAP
Ylin
16,36Alin
15,6VaihtoMäärä
89,7 9 414 615
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 11.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 23.2. | ||
2025 Q3 -tulosraportti 3.11.2025 | ||
2025 Q2 -tulosraportti 4.8.2025 | ||
Vuosittainen yhtiökokous 2025 12.6.2025 | ||
2025 Q1 -tulosraportti 5.5.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·18 t sittenBelieve in an unprecedentedly large marketing stunt!!! There are some who don't know who HIMS is now. If they subsequently start to focus on their smart part of the business, and they become medicine's answer to Robinhood - without obesity medicine being the most important focus. Then I believe that the way they can reduce the price of medicine and produce the same doses that fit perfectly for each individual person is brilliant. I believe the management is bold as brass - so one can think what one wants about that. Publicity and focus they have certainly gotten on their name. Believe this stock has a place in the future - and is worth much more than the current price when we hit summer!!! I am quite heavily invested in it!
·23 t sitten · MuokattuHims & Hers Health is the perfect symbol of the 2020s stock market: lots of hype, minimal substance, and a business model built on others' innovation. After their catastrophic Novo-stunt, it became clear how thin the ice was. The stock has collapsed almost 60% in three months, and suddenly the narrative of “disruption” has turned into pure survival. It looks less like a healthcare revolution and more like a parasitic company living off temu-medicine and smart marketing. The problem is simply that reality sooner or later catches up with the PowerPoint. And the market has apparently finally understood it.·19 t sittenOr it's brilliant marketing!!! Bold and over the line - but if that was the plan and they now end up helping those with less money to get cheaper medicine. Then people will have forgotten that they perhaps got the world's smartest marketing from a somewhat shady move! Let's see - I think HIMS has more control over what they're doing than most people think. So one can think it's smart or over the line…
·1 päivä sitten · MuokattuThis stock is "done" at least until Q2 2026. For those who are a bit disappointed ("bagholders") - there is a light deep in the tunnel - which is called "ZETA" - check it out before it's too late - that stock was also beaten by recent market trends, but their financial performance in Q4 2025 was phenomenal, but even after earnings they are far from the price targets they should be - considering HIMS' "tight" price increase - this could be a stock to convert to - but: NOTE: this is just the idea, not financial advice!
·2 päivää sittenExited some time ago. Good luck. Can be found at much lower levels.
·2 päivää sittenJust MINUS 9% in the pre-market🙈 - oh well, then goodbye!💸·2 päivää sittenDon't know - can't figure out at all what is gradually priced into Hims' fall - all the fat should be gone at least
·2 päivää sittenMaybe something with lawsuits of a size we don't know yet, as well as high debt - a bankruptcy is not unthinkable if they are sued for 3-4 digit million amounts measured in dollars. Unless they can raise capital by issuing new shares, which will lead to an even lower share price.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
3 päivää sitten
‧1 t 4 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·18 t sittenBelieve in an unprecedentedly large marketing stunt!!! There are some who don't know who HIMS is now. If they subsequently start to focus on their smart part of the business, and they become medicine's answer to Robinhood - without obesity medicine being the most important focus. Then I believe that the way they can reduce the price of medicine and produce the same doses that fit perfectly for each individual person is brilliant. I believe the management is bold as brass - so one can think what one wants about that. Publicity and focus they have certainly gotten on their name. Believe this stock has a place in the future - and is worth much more than the current price when we hit summer!!! I am quite heavily invested in it!
- ·23 t sitten · MuokattuHims & Hers Health is the perfect symbol of the 2020s stock market: lots of hype, minimal substance, and a business model built on others' innovation. After their catastrophic Novo-stunt, it became clear how thin the ice was. The stock has collapsed almost 60% in three months, and suddenly the narrative of “disruption” has turned into pure survival. It looks less like a healthcare revolution and more like a parasitic company living off temu-medicine and smart marketing. The problem is simply that reality sooner or later catches up with the PowerPoint. And the market has apparently finally understood it.·19 t sittenOr it's brilliant marketing!!! Bold and over the line - but if that was the plan and they now end up helping those with less money to get cheaper medicine. Then people will have forgotten that they perhaps got the world's smartest marketing from a somewhat shady move! Let's see - I think HIMS has more control over what they're doing than most people think. So one can think it's smart or over the line…
- ·1 päivä sitten · MuokattuThis stock is "done" at least until Q2 2026. For those who are a bit disappointed ("bagholders") - there is a light deep in the tunnel - which is called "ZETA" - check it out before it's too late - that stock was also beaten by recent market trends, but their financial performance in Q4 2025 was phenomenal, but even after earnings they are far from the price targets they should be - considering HIMS' "tight" price increase - this could be a stock to convert to - but: NOTE: this is just the idea, not financial advice!
- ·2 päivää sittenExited some time ago. Good luck. Can be found at much lower levels.
- ·2 päivää sittenJust MINUS 9% in the pre-market🙈 - oh well, then goodbye!💸·2 päivää sittenDon't know - can't figure out at all what is gradually priced into Hims' fall - all the fat should be gone at least·2 päivää sittenMaybe something with lawsuits of a size we don't know yet, as well as high debt - a bankruptcy is not unthinkable if they are sued for 3-4 digit million amounts measured in dollars. Unless they can raise capital by issuing new shares, which will lead to an even lower share price.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
270
Myynti
Määrä
19
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
16,36VWAP
Alin
15,6VaihtoMäärä
89,7 9 414 615
VWAP
Ylin
16,36Alin
15,6VaihtoMäärä
89,7 9 414 615
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 11.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 23.2. | ||
2025 Q3 -tulosraportti 3.11.2025 | ||
2025 Q2 -tulosraportti 4.8.2025 | ||
Vuosittainen yhtiökokous 2025 12.6.2025 | ||
2025 Q1 -tulosraportti 5.5.2025 |
2025 Q4 -tulosraportti
3 päivää sitten
‧1 t 4 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 11.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 23.2. | ||
2025 Q3 -tulosraportti 3.11.2025 | ||
2025 Q2 -tulosraportti 4.8.2025 | ||
Vuosittainen yhtiökokous 2025 12.6.2025 | ||
2025 Q1 -tulosraportti 5.5.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·18 t sittenBelieve in an unprecedentedly large marketing stunt!!! There are some who don't know who HIMS is now. If they subsequently start to focus on their smart part of the business, and they become medicine's answer to Robinhood - without obesity medicine being the most important focus. Then I believe that the way they can reduce the price of medicine and produce the same doses that fit perfectly for each individual person is brilliant. I believe the management is bold as brass - so one can think what one wants about that. Publicity and focus they have certainly gotten on their name. Believe this stock has a place in the future - and is worth much more than the current price when we hit summer!!! I am quite heavily invested in it!
- ·23 t sitten · MuokattuHims & Hers Health is the perfect symbol of the 2020s stock market: lots of hype, minimal substance, and a business model built on others' innovation. After their catastrophic Novo-stunt, it became clear how thin the ice was. The stock has collapsed almost 60% in three months, and suddenly the narrative of “disruption” has turned into pure survival. It looks less like a healthcare revolution and more like a parasitic company living off temu-medicine and smart marketing. The problem is simply that reality sooner or later catches up with the PowerPoint. And the market has apparently finally understood it.·19 t sittenOr it's brilliant marketing!!! Bold and over the line - but if that was the plan and they now end up helping those with less money to get cheaper medicine. Then people will have forgotten that they perhaps got the world's smartest marketing from a somewhat shady move! Let's see - I think HIMS has more control over what they're doing than most people think. So one can think it's smart or over the line…
- ·1 päivä sitten · MuokattuThis stock is "done" at least until Q2 2026. For those who are a bit disappointed ("bagholders") - there is a light deep in the tunnel - which is called "ZETA" - check it out before it's too late - that stock was also beaten by recent market trends, but their financial performance in Q4 2025 was phenomenal, but even after earnings they are far from the price targets they should be - considering HIMS' "tight" price increase - this could be a stock to convert to - but: NOTE: this is just the idea, not financial advice!
- ·2 päivää sittenExited some time ago. Good luck. Can be found at much lower levels.
- ·2 päivää sittenJust MINUS 9% in the pre-market🙈 - oh well, then goodbye!💸·2 päivää sittenDon't know - can't figure out at all what is gradually priced into Hims' fall - all the fat should be gone at least·2 päivää sittenMaybe something with lawsuits of a size we don't know yet, as well as high debt - a bankruptcy is not unthinkable if they are sued for 3-4 digit million amounts measured in dollars. Unless they can raise capital by issuing new shares, which will lead to an even lower share price.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
270
Myynti
Määrä
19
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
16,36VWAP
Alin
15,6VaihtoMäärä
89,7 9 414 615
VWAP
Ylin
16,36Alin
15,6VaihtoMäärä
89,7 9 414 615
Välittäjätilasto
Dataa ei löytynyt